drugset / Trial / NCT03079973
Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this phase III study is to evaluate the efficacy, systemic safety and local tolerability of P-3073 (calcipotriene 0.005%) nail solution in patients with mild to moderate psoriatic fingernail/s.
Timeline
- Start
- 2017-05-15
- Primary completion
- 2018-07
- Completion
- 2018-07
Outcome
Outcome not reported
Stopped: “Project development priorities changed.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | P-3073 | Unknown | 0.005 % | Topical |